48,830
edits
(→Classification: more) |
(→Classification: tweak) |
||
Line 22: | Line 22: | ||
#**FHL2.<ref>{{OMIM|603553}}</ref> | #**FHL2.<ref>{{OMIM|603553}}</ref> | ||
#Secondary: | #Secondary: | ||
#*Infection, e.g. [[EBV]] (most common<ref>{{Ref WMSP|576}}</ref>),<ref name=pmid20819601>{{cite journal |author=Jin YK, Xie ZD, Yang S, Lu G, Shen KL |title=Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China |journal=Chin. Med. J. |volume=123 |issue=11 |pages=1426–30 |year=2010 |month=June |pmid=20819601 |doi= |url=}}</ref> [[HIV]]. | #*Infection, e.g. [[EBV]] (most common infectious etiology<ref>{{Ref WMSP|576}}</ref>),<ref name=pmid20819601>{{cite journal |author=Jin YK, Xie ZD, Yang S, Lu G, Shen KL |title=Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China |journal=Chin. Med. J. |volume=123 |issue=11 |pages=1426–30 |year=2010 |month=June |pmid=20819601 |doi= |url=}}</ref> [[HIV]]. | ||
#*Malignancy. | #*Malignancy. | ||
#*Rheumatologic condition. | #*Rheumatologic condition. |
edits